AtriCure, Inc.
General ticker "ATRC" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.6B (TTM average)
AtriCure, Inc. follows the US Stock Market performance with the rate: 45.0%.
Estimated limits based on current volatility of 2.1%: low 29.69$, high 31.12$
Factors to consider:
- Total employees count: 1300 as of 2024
- US accounted for 26.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market acceptance, Market competition, Clinical trial uncertainties, Manufacturing disruptions, Operational and conduct risks
- Current price 10.8% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [33.67$, 50.62$]
- 2026-12-31 to 2027-12-31 estimated range: [35.53$, 53.24$]
Financial Metrics affecting the ATRC estimates:
- Negative: with PPE of -311.8 at the end of fiscal year the price was very high
- Positive: -4.75 < Operating profit margin, % of -0.64
- Positive: Shareholder equity ratio, % of 75.20 > 64.29
- Positive: Inventory ratio change, % of -1.13 <= -0.75
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of -1.72
- Positive: -4.43 < Investing cash flow per share per price, % of -0.75
- Positive: -9.07 < Industry operating profit margin (median), % of -2.56
Short-term ATRC quotes
Long-term ATRC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $399.25MM | $465.31MM | $534.53MM |
| Operating Expenses | $425.93MM | $505.32MM | $537.98MM |
| Operating Income | $-26.68MM | $-40.01MM | $-3.45MM |
| Non-Operating Income | $-3.16MM | $-3.66MM | $-6.72MM |
| Interest Expense | $6.92MM | $6.41MM | $5.88MM |
| R&D Expense | $73.92MM | $96.18MM | $90.17MM |
| Income(Loss) | $-29.85MM | $-43.67MM | $-10.16MM |
| Taxes | $0.59MM | $1.02MM | $1.28MM |
| Profit(Loss)* | $-30.44MM | $-89.40MM | $-11.45MM |
| Stockholders Equity | $466.17MM | $460.97MM | $491.94MM |
| Inventory | $67.90MM | $75.33MM | $78.49MM |
| Assets | $613.93MM | $609.33MM | $654.18MM |
| Operating Cash Flow | $4.48MM | $12.20MM | $57.33MM |
| Capital expenditure | $42.00MM | $23.46MM | $9.05MM |
| Investing Cash Flow | $21.82MM | $30.23MM | $-14.55MM |
| Financing Cash Flow | $-0.03MM | $-3.60MM | $1.18MM |
| Earnings Per Share** | $-0.66 | $-1.90 | $-0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.